Latest Earnings Results: Q3 '26
Estimated EPS
$0.27
Reported EPS
$0.21
Surprise
-21.12%
Estimated Rev
$1.53B
Reported Rev
$1.54B
Surprise
+0.5%
• Reported GAAP EPS of $0.21 up 23.53% YoY • Reported revenue of $1.54B up 3.01% YoY • Chemours expects 2026 Net Sales to grow approximately 2% over 2025 and Adjusted EBITDA between $775M and $800M; Q4 consolidated Adjusted EBITDA is expected to range between $160M and $185M.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $0.14 | -- | -- | N/A |
Q3 '26 | $0.27 | $0.21 | -21.12% | MISSED |
Q2 '26 | $0.50 | $0.42 | -15.38% | MISSED |
Q1 '26 | -$0.04 | $0.05 | 227.16% | BEAT |
Q4 '25 | $0.07 | $0.05 | -31.22% | MISSED |